Tresiba is a long-acting insulin prescribed to manage blood sugar levels in adults and children over 1 year old with type 1 and type 2 diabetes. The appropriate Tresiba dosage varies depending on ...

SEOUL, SOUTH KOREA - Media OutReach Newswire - 9 July 2025 - Health2Sync, Asia's leading digital chronic disease management platform, announced the successful integration of Smart Cap Mallya® for ...

Novo Nordisk has launched Wegovy in India, a weight-loss drug challenging Eli Lilly's Mounjaro. Available by June 2025, Wegovy is a once-weekly injectable using a user-friendly FlexTouch pen.

Dosage for Tresiba (insulin degludec) depends on the type of diabetes (type 1 or type 2) it is prescribed for and other factors. Your doctor may adjust your dosage over the course of your treatment.

There are currently shortages of the Tresiba FlexTouch insulin pen which could affect people living with diabetes who take Tresiba insulin. Here’s what you need to know.

Image by Rosa Alfaro Oré. An English summary of this report is below. The original report, published in Spanish in Salud con lupa, follows. The pharmaceutical oligopoly formed by Novo Nordisk, Eli ...

PEOPLE with type 1 diabetes fear their lives could be at risk as the UK faces shortages of "vital" insulin. Insulin, which helps the body regulate blood sugar levels, is one of hundreds of drugs ...

The scarcity of insulin is causing stress among those with type 1 diabetes. Reports of insulin scarcity have sparked concerns among patients, including one NHS doctor who shared her struggle to obtain ...

Please provide your email address to receive an email when new articles are posted on . O’Brien: An initial response is to consider the individual’s insurance formulary. However, when an insurance ...